ID: ALA4796490

Max Phase: Preclinical

Molecular Formula: C24H39N5O13

Molecular Weight: 605.60

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](COc4ccc([N+](=O)[O-])cc4)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O

Standard InChI:  InChI=1S/C24H39N5O13/c25-6-12-16(31)18(33)19(34)24(39-12)42-22-11(27)5-10(26)21(20(22)35)41-23-17(32)14(28)15(30)13(40-23)7-38-9-3-1-8(2-4-9)29(36)37/h1-4,10-24,30-35H,5-7,25-28H2/t10-,11+,12-,13-,14+,15-,16-,17-,18+,19-,20-,21+,22-,23-,24-/m1/s1

Standard InChI Key:  UWAABXLJFCBPEX-OSMKSXLKSA-N

Associated Targets(Human)

Gap junction beta-2 protein 74 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Gap junction alpha-1 protein 92 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 605.60Molecular Weight (Monoisotopic): 605.2544AlogP: -5.30#Rotatable Bonds: 9
Polar Surface Area: 314.75Molecular Species: BASEHBA: 17HBD: 10
#RO5 Violations: 3HBA (Lipinski): 18HBD (Lipinski): 14#RO5 Violations (Lipinski): 3
CX Acidic pKa: 12.05CX Basic pKa: 9.54CX LogP: -4.79CX LogD: -10.21
Aromatic Rings: 1Heavy Atoms: 42QED Weighted: 0.09Np Likeness Score: 0.82

References

1. Subedi YP,Kjellgren A,Roberts P,Montgomery H,Thackeray N,Fiori MC,Altenberg GA,Chang CT.  (2020)  Amphiphilic aminoglycosides with increased selectivity for inhibition of connexin 43 (Cx43) hemichannels.,  203  [PMID:32679454] [10.1016/j.ejmech.2020.112602]

Source